|
|
 |
|
Viewing report
|
|
 |
 |
Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies
GBI Research, Oct 2010, Pages: 120
“Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increases Pharmaceutical Companies' Adoption of New Sales Models and Technologies”, provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the sales force effectiveness strategies that shape the industry dynamics for the key geographies: the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and analyzes the licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Scope
The scope of this report includes:
- Annualized market data from 2009, forecast forward to 2016.
- Analysis of the leading technology in this space
- Analysis of the R&D models
- Market characterization
- Key drivers and barriers that have a significant impact on the market.
- Competitive benchmarking of leading companies.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop key strategies to reduce expenditure on sales force and by increasing efficiency
- Develop and understanding of how companies use tools and models in order to improve the sales force productivity
- Make informed decisions with respect to sales force effectiveness
- Identify the leading technology providers for collaborations along with their key capabilities
- Make more informed business decisions from the insightful and in-depth analysis of the sales force effectiveness and the factors shaping it.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism
Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology
Lifesciences IT - 2011 Yearbook
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Pharmaceutical Research and Development (R&D) - Increasing Efficiency through Information Technology and Externalization
EvaluatePharma® Yearbook - Company Performance Tables
Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
|
 |
|
|